REFERENCES
1. Lavee J, Onik G, Mikus P, Rubinsky B. A novel nonthermal energy source for surgical epicardial atrial ablation: irreversible electroporation. Heart Surg Forum 2007;10:E162-7.
2. Jones JL, Jones RE, Balasky G. Microlesion formation in myocardial cells by high-intensity electric field stimulation. Am J Physiol 1987;253:H480-6.
3. Dev SB, Hofmann GA. Electrochemotherapy - a novel method of cancer treatment. Cancer Treat Rev 1994;20:105-15.
4. Bakhtiari S, Manshadi MKD, Candas M, Beskok A. Changes in electrical capacitance of cell membrane reflect drug partitioning-induced alterations in lipid bilayer. Micromachines 2023;14:316.
5. Napotnik T, Polajžer T, Miklavčič D. Cell death due to electroporation - a review. Bioelectrochemistry 2021;141:107871.
6. Aycock KN, Campelo SN, Davalos RV. A comparative modeling study of thermal mitigation strategies in irreversible electroporation treatments. J Heat Transfer 2022;144:031206.
7. Dunki-Jacobs EM, Philips P, Martin RC 2nd. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model. Br J Surg 2014;101:1113-21.
8. Ruwald MH, Johannessen A, Hansen ML, Haugdal M, Worck R, Hansen J. Utility of high-density 3D-bipolar voltage map after pulmonary vein isolation by pulsed-field ablation. JACC Clin Electrophysiol 2023;9:588-90.
9. Lafarge EJ, Muller P, Schroder AP, Zaitseva E, Behrends JC, Marques CM. Activation energy for pore opening in lipid membranes under an electric field. Proc Natl Acad Sci USA 2023;120:e2213112120.
10. Guo F, Wang J, Deng Q, et al. Effects of pulsed field ablation on autonomic nervous system in paroxysmal atrial fibrillation: a pilot study. Heart Rhythm 2023;20:329-38.
11. Musikantow DR, Neuzil P, Petru J, et al. Pulsed field ablation to treat atrial fibrillation: autonomic nervous system effects. JACC Clin Electrophysiol 2023;9:481-93.
12. Stojadinović P, Wichterle D, Peichl P, et al. Autonomic changes are more durable after radiofrequency than pulsed electric field pulmonary vein ablation. JACC Clin Electrophysiol 2022;8:895-904.
13. Howard B, Verma A, Tzou WS, et al. Effects of electrode-tissue proximity on cardiac lesion formation using pulsed field ablation. Circ Arrhythm Electrophysiol 2022;15:e011110.
14. Belalcazar A. Safety and efficacy aspects of pulsed field ablation catheters as a function of electrode proximity to blood and energy delivery method. 2021;2:560-9.
15. Mattison L, Verma A, Tarakji KG, et al. Effect of contact force on pulsed field ablation lesions in porcine cardiac tissue. J Cardiovasc Electrophysiol 2023;34:693-9.
16. Kawamura I, Reddy VY, Santos-Gallego CG, et al. Electrophysiology, pathology, and imaging of pulsed field ablation of scarred and healthy ventricles in swine. Circ Arrhythm Electrophysiol 2023;16:e011369.
17. Verma A, Boersma L, Haines DE, et al. First-in-human experience and acute procedural outcomes using a novel pulsed field ablation system: the PULSED AF pilot trial. Circ Arrhythm Electrophysiol 2022;15:e010168.
18. González-Suárez A, Pérez JJ, O'Brien B, Elahi A. In silico modelling to assess the electrical and thermal disturbance provoked by a metal intracoronary stent during epicardial pulsed electric field ablation. J Cardiovasc Dev Dis 2022;9:458.
19. Reddy VY, Gerstenfeld EP, Natale A, et al. ADVENT Investigators. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med 2023;389:1660-71.
20. Iasiello M, Andreozzi A, Bianco N, Vafai K. The porous media theory applied to radiofrequency catheter ablation. HFF 2020;30:2669-81.
21. Iasiello M, Andreozzi A, Bianco N, Vafai K. Effects of pulsed radiofrequency source on cardiac ablation. Bioengineering 2023;10:227.
22. Pérez JJ, Nadal E, Berjano E, González-Suárez A. Computer modeling of radiofrequency cardiac ablation including heartbeat-induced electrode displacement. Comput Biol Med 2022;144:105346.
23. Stöckigt F, Schrickel JW, Andrié R, Lickfett L. Atrioesophageal fistula after cryoballoon pulmonary vein isolation. J Cardiovasc Electrophysiol 2012;23:1254-7.
24. Restrepo AJ, Dickfeld TM. 62 - Computed Tomography for Electrophysiology. In: Douglas P. Zipes, José Jalife, William G. Stevenson, Editors. Cardiac electrophysiology: from cell to bedside. Amsterdam: Elsevier; 2018. pp. 587-600.
25. Ahero A, Frauenfelder T, Breitenstein A, Ammann P, Kucher N, Barco S. Partially reversible lung consolidation after revascularization of a total occlusion of both left pulmonary veins following ablation of atrial fibrillation: a case report. Eur Heart J Case Rep 2023;7:ytad057.
26. Vanderlaan RD, Caldarone CA. Pulmonary vein stenosis: incremental knowledge gains to improve outcomes. Children 2021;8:481.
27. Samuel M, Khairy P, Mongeon FP, et al. Pulmonary vein stenosis after atrial fibrillation ablation: insights from the ADVICE trial. Can J Cardiol 2020;36:1965-74.
28. Teunissen C, Velthuis BK, Hassink RJ, et al. Incidence of pulmonary vein stenosis after radiofrequency catheter ablation of atrial fibrillation. JACC Clin Electrophysiol 2017;3:589-98.
29. Kawamura I, Reddy VY, Wang BJ, et al. Pulsed field ablation of the porcine ventricle using a focal lattice-tip catheter. Circ Arrhythm Electrophysiol 2022;15:e011120.
30. Roberts-Thomson KC, Steven D, Seiler J, et al. Coronary artery injury due to catheter ablation in adults: presentations and outcomes. Circulation 2009;120:1465-73.
31. Yue-Chun L, Jia-Feng L, Xue-Qiang G, Peng C. Chronic left coronary artery stenosis after radiofrequency ablation of idiopathic premature ventricular contraction originating from left coronary sinus cusp. Circ Arrhythm Electrophysiol 2016;9:e004353.
32. Caldwell JC, Fath-Odoubadi F, Garratt CJ. Right coronary artery damage during cavotricuspid isthmus ablation. Pacing Clin Electrophysiol 2010;33:e110-3.
33. Stavrakis S, Jackman WM, Nakagawa H, et al. Risk of coronary artery injury with radiofrequency ablation and cryoablation of epicardial posteroseptal accessory pathways within the coronary venous system. Circ Arrhythm Electrophysiol 2014;7:113-9.
34. Li FH, Zeng R, Zhang Q, Ma CS. The efficacy and safety of pulsed-field ablation in para-Hisian paroxysmal supraventricular tachycardia: first-in-human pilot trial. Eur Heart J 2023;44:ehac779.026.
35. Adeliño R, Combes S, El Bouazzaoui R, Albenque JP, Combes N, Boveda S. Pulsed-field ablation of recurrent right atrial tachycardia: expanding the use of electroporation beyond atrial fibrillation. Europace 2023;25:1512.
36. Phlips T, Verhaeghe L, Antole N, Koopman P, Vijgen J. Pulsed field ablation using a focal contact force catheter allowed successful ablation of a focal right atrial tachycardia in the proximity of the phrenic nerve. HeartRhythm Case Rep 2023;9:434-6.
37. Winkelmann S, Lemoine M, Wuerger T, et al. Safety of pulsed-field ablation in patients with cardiac implantable electronic devices. A single-center pilot study. EP Europace 2022;24:euac053.234.
38. Reddy VY, Lehmann JW, Gerstenfeld EP, et al. A randomized controlled trial of pulsed field ablation versus standard-of-care ablation for paroxysmal atrial fibrillation: the ADVENT trial rationale and design. Heart Rhythm O2 2023;4:317-28.
39. Fender EA, Widmer RJ, Hodge DO, et al. Severe pulmonary vein stenosis resulting from ablation for atrial fibrillation: presentation, management, and clinical outcomes. Circulation 2016;134:1812-21.
40. Meckes D, Emami M, Fong I, Lau DH, Sanders P. Pulsed-field ablation: computational modeling of electric fields for lesion depth analysis. Heart Rhythm O2 2022;3:433-40.
41. Gómez-Barea M, García-Sánchez T, Ivorra A. A computational comparison of radiofrequency and pulsed field ablation in terms of lesion morphology in the cardiac chamber. Sci Rep 2022;12:16144.
42. Zang L, Gu K, Ji X, Zhang H, Yan S, Wu X. Comparative analysis of temperature rise between convective heat transfer method and computational fluid dynamics method in an anatomy-based left atrium model during pulsed field ablation: a computational study. J Cardiovasc Dev Dis 2023;10:56.
43. García-Sánchez T, Amorós-Figueras G, Jorge E, et al. Parametric study of pulsed field ablation with biphasic waveforms in an in vivo heart model: the role of frequency. Circ Arrhythm Electrophysiol 2022;15:e010992.
44. van Driel VJ, Neven KG, van Wessel H, et al. Pulmonary vein stenosis after catheter ablation: electroporation versus radiofrequency. Circ Arrhythm Electrophysiol 2014;7:734-8.
45. Koruth J, Kuroki K, Iwasawa J, et al. Preclinical evaluation of pulsed field ablation: electrophysiological and histological assessment of thoracic vein isolation. Circ Arrhythm Electrophysiol 2019;12:e007781.
46. Koruth JS, Kuroki K, Kawamura I, et al. Focal pulsed field ablation for pulmonary vein isolation and linear atrial lesions: a preclinical assessment of safety and durability. Circ Arrhythm Electrophysiol 2020;13:e008716.
47. Ye X, Liu S, Yin H, et al. Study on optimal parameter and target for pulsed-field ablation of atrial fibrillation. Front Cardiovasc Med 2021;8:690092.
48. Hsu JC, Gibson D, Banker R, et al. In vivo porcine characterization of atrial lesion safety and efficacy utilizing a circular pulsed-field ablation catheter including assessment of collateral damage to adjacent tissue in supratherapeutic ablation applications. J Cardiovasc Electrophysiol 2022;33:1480-8.
49. Zhao Z, Chen Y, Wu B, et al. Pulsed-field ablation using a novel ablation-mapping integrated system for pulmonary vein isolation-a preliminary animal study. J Cardiovasc Dev Dis 2022;9:425.
50. Koruth J, Kawamura I, Dukkipati SR, Neuzil P, Reddy VY. Preclinical assessment of the feasibility, safety and lesion durability of a novel 'single-shot' pulsed field ablation catheter for pulmonary vein isolation. Europace 2023;25:1369-78.
51. Howard B, Haines DE, Verma A, et al. Reduction in pulmonary vein stenosis and collateral damage with pulsed field ablation compared with radiofrequency ablation in a canine model. Circ Arrhythm Electrophysiol 2020;13:e008337.
52. Koruth J, Verma A, Kawamura I, et al. PV isolation using a spherical array pfa catheter: preclinical assessment and comparison to radiofrequency ablation. JACC Clin Electrophysiol 2023;9:652-66.
53. Reddy VY, Koruth J, Jais P, et al. Ablation of atrial fibrillation with pulsed electric fields: an ultra-rapid, tissue-selective modality for cardiac ablation. JACC Clin Electrophysiol 2018;4:987-95.
54. Reddy VY, Neuzil P, Koruth JS, et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol 2019;74:315-26.
55. Reddy VY, Anic A, Koruth J, et al. Pulsed field ablation in patients with persistent atrial fibrillation. J Am Coll Cardiol 2020;76:1068-80.
56. Kuroki K, Whang W, Eggert C, et al. Ostial dimensional changes after pulmonary vein isolation: Pulsed field ablation vs radiofrequency ablation. Heart Rhythm 2020;17:1528-35.
57. Reddy VY, Dukkipati SR, Neuzil P, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol 2021;7:614-27.
58. Chen S, Chun JKR, Bordignon S, et al. Pulsed field ablation-based pulmonary vein isolation in atrial fibrillation patients with cardiac implantable electronic devices: practical approach and device interrogation (PFA in CIEDs). J Interv Card Electrophysiol 2023;66:1929-38.
59. Gunawardene MA, Schaeffer BN, Jularic M, et al. Pulsed field ablation in patients with complex consecutive atrial tachycardia in conjunction with ultra-high density mapping: Proof of concept. J Cardiovasc Electrophysiol 2022;33:2431-43.
60. Turagam MK, Neuzil P, Petru J, et al. PV isolation using a spherical array PFA catheter: application repetition and lesion durability (PULSE-EU Study). JACC Clin Electrophysiol 2023;9:638-48.
61. Tohoku S, Chun KRJ, Bordignon S, et al. Findings from repeat ablation using high-density mapping after pulmonary vein isolation with pulsed field ablation. Europace 2023;25:433-40.
62. Duytschaever M, De Potter T, Grimaldi M, et al. inspIRE Trial Investigators. Paroxysmal atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system: 1-year outcomes of the multicenter inspIRE study. Circ Arrhythm Electrophysiol 2023;16:e011780.
63. Ekanem E, Reddy VY, Schmidt B, et al. MANIFEST-PF Cooperative. Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF). Europace 2022;24:1256-66.
64. Repp ML, Chinyere IR. Opportunities and challenges in catheter-based irreversible electroporation for ventricular tachycardia. Pathophysiology 2024;31:32-43.
65. Yavin HD, Higuchi K, Sroubek J, Younis A, Zilberman I, Anter E. Pulsed-field ablation in ventricular myocardium using a focal catheter: the impact of application repetition on lesion dimensions. Circ Arrhythm Electrophysiol 2021;14:e010375.
66. Koruth JS, Kuroki K, Iwasawa J, et al. Endocardial ventricular pulsed field ablation: a proof-of-concept preclinical evaluation. Europace 2020;22:434-9.
67. Sandhu U, Alkukhun L, Kheiri B, et al. In vivo pulsed-field ablation in healthy vs. chronically infarcted ventricular myocardium: biophysical and histologic characterization. Europace 2023;25:1503-9.
68. Hunter DW, Kostecki G, Fish JM, Jensen JA, Tandri H. In vitro cell selectivity of reversible and irreversible: electroporation in cardiac tissue. Circ Arrhythm Electrophysiol 2021;14:e008817.
69. Maor E, Ivorra A, Leor J, Rubinsky B. The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 2007;6:307-12.
70. Maor E, Ivorra A, Rubinsky B. Non thermal irreversible electroporation: novel technology for vascular smooth muscle cells ablation. PLoS One 2009;4:e4757.
71. Maor E, Ivorra A, Mitchell JJ, Rubinsky B. Vascular smooth muscle cells ablation with endovascular nonthermal irreversible electroporation. J Vasc Interv Radiol 2010;21:1708-15.
72. Phillips M, Maor E, Rubinsky B. Nonthermal irreversible electroporation for tissue decellularization. J Biomech Eng 2010;132:091003.
73. Reddy VY, Petru J, Funasako M, et al. Coronary arterial spasm during pulsed field ablation to treat atrial fibrillation. Circulation 2022;146:1808-19.
74. Gunawardene MA, Schaeffer BN, Jularic M, et al. Coronary spasm during pulsed field ablation of the mitral isthmus line. JACC Clin Electrophysiol 2021;7:1618-20.
75. Wilber DJ. Pulsed-field ablation and the coronary arteries: not so simple. JACC Clin Electrophysiol 2022;8:1497-9.
76. du Pré BC, van Driel VJ, van Wessel H, et al. Minimal coronary artery damage by myocardial electroporation ablation. Europace 2013;15:144-9.
77. Neven K, van Driel V, van Wessel H, et al. Safety and feasibility of closed chest epicardial catheter ablation using electroporation. Circ Arrhythm Electrophysiol ;2014 7:913-9.
78. Neven K, van Driel V, van Wessel H, van Es R, Doevendans PA, Wittkampf F. Myocardial lesion size after epicardial electroporation catheter ablation after subxiphoid puncture. Circ Arrhythm Electrophysiol 2014;7:728-33.
79. Neven K, van Driel V, van Wessel H, van Es R, Doevendans PA, Wittkampf F. Epicardial linear electroporation ablation and lesion size. Heart Rhythm 2014;11:1465-70.
80. Im SI, Higuchi S, Lee A, et al. Pulsed field ablation of left ventricular myocardium in a swine infarct model. JACC Clin Electrophysiol 2022;8:722-31.
81. Ladejobi A, Christopoulos G, Tan N, et al. Effects of Pulsed Electric Fields on the Coronary Arteries in Swine. Circ Arrhythm Electrophysiol 2022;15:e010668.
82. Buist TJ, Groen MHA, Wittkampf FHM, et al. Feasibility of linear irreversible electroporation ablation in the coronary sinus. Cardiovasc Eng Technol 2023;14:60-6.
83. Higuchi S, Im SI, Stillson C, et al. Effect of epicardial pulsed field ablation directly on coronary arteries. JACC Clin Electrophysiol 2022;8:1486-96.
84. van Zyl M, Ladas TP, Tri JA, et al. Bipolar electroporation across the interventricular septum: electrophysiological, imaging, and histopathological characteristics. JACC Clin Electrophysiol 2022;8:1106-18.
